Considering the expression of activation and exhaustion markers PD-1 and TIM-3, our analysis revealed no significant differences in CD8+ T cells between HNSCC patients and HD (Fig. 1D), with double negative cells representing the highest fractions in both groups. This evidence concerns the gene HAVCR2 and Huntington disease.